Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2022 16:30 ET | Source: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 06, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
May 03, 2022 12:59 ET | Source: Neuronetics

NeuroStar Advanced Therapy for Mental Health Announces Partnership with Mental Health Advocate and Former Major League Baseball Player Drew Robinson

A Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial...
April 28, 2022 08:30 ET | Source: Neuronetics

Neuronetics to Report First Quarter 2022 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 28, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
April 11, 2022 08:00 ET | Source: Neuronetics; Greenbrook TMS

Greenbrook and Neuronetics Announce Strengthened Commercial Partnership to Build Awareness

TORONTO and MALVERN, Pa., April 11, 2022 (GLOBE NEWSWIRE) -- Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared,...
March 08, 2022 16:35 ET | Source: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
March 08, 2022 07:30 ET | Source: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

MALVERN, Pa., March 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients...
March 03, 2022 10:00 ET | Source: Neuronetics

NeuroStar® Advanced Therapy Launches New “Tap Into a New Possibility” Campaign for Depression Awareness

MALVERN, Pa., March 03, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
March 01, 2022 08:31 ET | Source: Neuronetics

MT Cap for NeuroStar Advanced Therapy for Mental Health Now Available Nationwide

MALVERN, Pa., March 01, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
February 22, 2022 16:30 ET | Source: Neuronetics

Neuronetics to Report Fourth Quarter and Fiscal Year 2021 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
February 22, 2022 07:30 ET | Source: Neuronetics

Neuronetics Announces Amendment of Credit Facility with SLR Investment Corp.

MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...